NASDAQ · Biotechnology

Viridian Therapeutics, Inc. (VRDN) Stock

$18.66 +1.74% NASDAQ: VRDN Healthcare

Valuation

MetricValue
Price$18.66
Market Cap$2.11B
P/E Ratio-5.50
P/B Ratio3.16
P/S Ratio30.90
EPS (TTM)$-3.32
52-Week High$34.29
52-Week Low$13.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-61.35%
ROA-35.27%
ROCE-39.21%
Gross Margin-511.27%
Operating Margin-511.27%
Net Margin-544.06%
Debt/Equity0.37
Current Ratio12.59

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0M$2.0M$0$0$71.0M
Operating Profit$-80.0M$-134.0M$-254.0M$-299.0M$-363.0M
Net Profit$-79.0M$-130.0M$-238.0M$-270.0M$-343.0M
EPS$-6.66$-3.91$-5.31$-3.98$-3.32
Op Margin-2690.8%-7579.2%-81035.0%-99018.2%-512.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$204.0M$435.0M$490.0M$742.0M$899.0M
Total Liabilities$16.0M$40.0M$48.0M$71.0M$177.0M
Cash$42.0M$156.0M$103.0M$100.0M$212.0M
Borrowings$1.0M$5.0M$21.0M$21.0M$51.0M

Latest News

Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN) Insider Monkey · Jul 15, 2026 Viridian Therapeutics (VRDN) Rebounds Sharply, Is The Valuation Still Too Rich? Simply Wall St. · Jul 15, 2026 Viridian Therapeutics (VRDN) Stock Still Looks Above Fair Value Today Simply Wall St. · Jul 15, 2026 “Stay Invested”: Wells Fargo Picks 2 Stocks to Buy as It Stays Bullish on the Market TipRanks · Jul 14, 2026 Wedbush Sees Commercial Edge for Viridian (VRDN) After FDA Milestone Insider Monkey · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-55.0M$-94.0M$-184.0M$-232.0M$-276.0M
Investing Cash Flow$-75.0M$-116.0M$-95.0M$-229.0M$-38.0M
Financing Cash Flow$-6.0M$-19.0M$9.0M$-21.0M$50.0M
Net Cash Flow$-4.0M$113.0M$-53.0M$-3.0M$113.0M
Free Cash Flow$-55.0M$-95.0M$-185.0M$-233.0M$-277.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.61
EV / EBITDA-6.18
FCF Yield-15.24%
Quick Ratio16.95
Interest Coverage-21.40
Return 1Y7.35%
Return 3Y-4.22%
Return 5Y12.03%

Ownership

Insiders Held0.14%
Institutions Held111.89%
Institutions Float Held112.05%
Institutional HolderSharesReport Date
FMR, LLC15,379,3772026-03-31
Blackrock Inc.7,831,4752026-03-31
Bellevue Group AG6,726,1442026-03-31
State Street Corporation4,672,8852026-03-31
Vanguard Capital Management LLC4,167,2012026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EYPTEyePoint, Inc. $3.40 -1.73% -0.91 $285.06M 0.00%
OCULOcular Therapeutix, Inc. $7.54 +0.40% -5.56 $1.65B 0.00%
OTLKOutlook Therapeutics, Inc. $0.60 +6.19% -0.32 $111.99M 0.00%

About Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. is led by CEO Stephen F. Mahoney, employs 143 people, headquartered in US, publicly traded since 2014.

Viridian Therapeutics, Inc. (VRDN) stock trades at $18.66 with a market capitalization of $2.11B. The stock is valued at a price-to-earnings (P/E) ratio of -5.50, price-to-book of 3.16, price-to-sales of 30.90. Over the past 52 weeks the stock has ranged between $13.18 and $34.29, and currently trades 45.6% below its 52-week high.

On profitability, Viridian Therapeutics, Inc. generates a return on equity (ROE) of -61.35%, return on capital employed of -39.21%, an operating margin of -511.27%, a net profit margin of -544.06%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides